Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

OBJECTIVES: There is little known about the impact of SARS-CoV-2 on patients with inflammatory rheumatic and musculoskeletal diseases (iRMD). We examined epidemiological characteristics associated with severe disease, then with death. We also compared mortality between patients hospitalised for COVI...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712850/
https://www.ncbi.nlm.nih.gov/pubmed/33268442
http://dx.doi.org/10.1136/annrheumdis-2020-218310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712850/
https://www.ncbi.nlm.nih.gov/pubmed/33268442
http://dx.doi.org/10.1136/annrheumdis-2020-218310

Ejemplares similares